Justinova Zuzana, Tanda Gianluigi, Redhi Godfrey H, Goldberg Steven R
Preclinical Pharmacology Section, Behavioral Neuroscience Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, Baltimore, MD 21224, USA.
Psychopharmacology (Berl). 2003 Sep;169(2):135-40. doi: 10.1007/s00213-003-1484-0. Epub 2003 Jun 24.
Interest in therapeutic activities of cannabinoids has been restrained by the fact that they are most often mediated through activation of cannabinoid CB1 receptors, the same receptors that mediate the effects of delta9-tetrahydrocannabinol (THC) and are responsible for the abuse liability of marijuana. Persistent intravenous self-administration of THC by animals was first demonstrated in squirrel monkeys and shown to be mediated by CB1 receptors, but monkeys in the study had a history of cocaine self-administration, raising the possibility that persistent neurobiological adaptations might subsequently predispose animals to self-administer THC.
To demonstrate persistent intravenous self-administration of THC in drug-naive squirrel monkeys.
Monkeys with no history of exposure to other drugs learned to press a lever for intravenous injections (0.2 ml in 0.2 s) of THC under a 10-response, fixed-ratio schedule with a 60-s time-out after each injection. Acquisition of THC self-administration was rapid and the final schedule was reached in 11-34 sessions. Dose of THC was then varied from 1 to 16 microg/kg per injection with vehicle extinction following each dose of THC.
THC maintained significantly higher numbers of self-administered injections per session and higher rates of responding than vehicle at doses of 2, 4 and 8 microg/kg per injection, with maximal rates of responding at 4 microg/kg per injection. Response rates, injections per session and total THC intake per session were two- to three-fold greater in monkeys with no history of exposure to other drugs compared to previous findings in monkeys with a history of cocaine self-administration.
THC can act as an effective reinforcer of drug-taking behavior in monkeys with no history of exposure to other drugs, suggesting that self-administration of THC by monkeys provides a reliable animal model of human marijuana abuse.
大麻素的治疗活性一直受到限制,因为它们通常是通过激活大麻素CB1受体来介导的,而这些受体同样介导了δ9-四氢大麻酚(THC)的作用,并导致了大麻的滥用倾向。动物持续静脉注射THC的行为最早在松鼠猴身上得到证实,并表明是由CB1受体介导的,但该研究中的猴子有可卡因自我给药史,这增加了持续的神经生物学适应可能随后使动物倾向于自我给药THC的可能性。
在未接触过其他药物的松鼠猴中证明持续静脉注射THC的行为。
没有接触过其他药物史的猴子学会在每次注射后有60秒超时的10次反应固定比率时间表下按压杠杆以静脉注射THC(0.2秒内注射0.2毫升)。THC自我给药的习得很快,在11-34次实验中达到最终时间表。然后将THC的剂量从每次注射1至16微克/千克进行变化,每次THC剂量后进行溶剂消退。
在每次注射剂量为2、4和8微克/千克时,THC维持的每次实验自我给药注射次数显著高于溶剂,且反应率更高,在每次注射4微克/千克时反应率最高。与先前有可卡因自我给药史的猴子的研究结果相比,没有接触过其他药物史的猴子的反应率、每次实验注射次数和每次实验THC总摄入量高出两到三倍。
THC可以在没有接触过其他药物史的猴子中作为药物摄取行为的有效强化剂,这表明猴子自我给药THC提供了一种可靠的人类大麻滥用动物模型。